Case File
efta-02519958DOJ Data Set 11OtherEFTA02519958
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02519958
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Alan S Halperin <MI=
Sent:
Friday, September 20, 2013 1:54 PM
To:
Florness, Patty (US - New York); Jeffrey Epstein; Banigan, Russell (US - Jericho); Csan,
Stephanie (US - Parsippany)
Subject:
Re: Sales Tax
I neglected to include the conference identification number. I apologize. It is
IRS Circular 230 disclosure:
To ensure compliance with requirements imposed by the IRS, we inform you that any U.S. federal tax advice contained
in this communication (including any attachments) is not intended or written to be used, and cannot be used, for the
purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or recommending to
another party any transaction or matter addressed herein.
Click Here for More Information <http://www.paulweiss.com/files/tbl_s29Publications/FileUpload5679/5647/230.pdf>
Alan S. Halperin I Partner
Paul, Weiss, Rifkind, Wharton & Garrison LLP
1285 Avenue of the Americas I New York, NY 10019-6064
From:
Alan S Halperin/Paul Weiss
To:
"Florness, Patty (US - New York)"
"Jeffrey Epstein" <jeevacation@gmail.com>,
"Banigan, Russell (US - Jericho)"
"Csan, Stephanie (US - Parsippany)"
09/20/2013 09:30 AM
Subject:
Sales Tax
We are set to chat at 2:30. Let's use the following call in number.
from an international location dial-
*
Enter your Conference ID, then press It
EFTA_R1_01656432
EFTA02519958
IRS Circular 230 disclosure:
To ensure compliance with requirements imposed by the IRS, we inform you that any U.S. federal tax advice contained
in this communication (including any attachments) is not intended or written to be used, and cannot be used, for the
purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or recommending to
another party any transaction or matter addressed herein.
Click Here for More Information <http://www.paulweiss.com/files/tbl_s29Publications/FileUpload5679/5647/230.pdf>
Alan S. Halperin I Partner
Paul, Weiss, Rifkind, Wharton & Garrison LLP
1285 Avenue of the Americas I New York, NY 10019-6064
This message is intended only for the use of the Addressee and may contain information that is privileged and
confidential. If you are not the intended recipient, you are hereby notified that any dissemination of this
communication is strictly prohibited. If you have received this communication in error, please erase all copies of the
message and its attachments and notify us immediately.
2
EFTA_R1_01656433
EFTA02519959
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
jeevacation@gmail.comPhone
2519958Phone
2519959URL
http://www.paulweiss.com/files/tbl_s29Publications/FileUpload5679/5647/230.pdfRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.